Team
Team
OnCuRNA is founded by a team of world-class scientists with multi-disciplinary skills in basic science, synthetic chemistry, preclinical research, drug development, and commercialization of therapeutics. We have collectively over 100 years of experience in science and drug development.
Dr. Nick Housley
PhD, DPT, PT
Founder and CEO
Dr. Nick Housley, PhD, DPT, PT is Assistant Professor in the School of Biological Sciences at Georgia Tech. Dr. Housley is the inventor OnCuRNA’s core technologies and an expert in in vivo preclinical studies. He has led the research teams in generating all of the preclinical, efficacy, toxicity, PK/PD data supporting OnCuRNA’s pipeline.
At Georgia Tech, Dr. Housley’s group develops nanostructures for multimodal applications in solid tumor cancers including drug delivery and cancer detection. A major area of focus involves the use of their nanohydrogel platform to precisely delivery therapeutic payloads to primary and metastatic cancer sites. Dr. Housley and his colleagues also investigate the fundamental interactions of nanostructures and biological environments that enable solid tumor targeting.